Palisade Bio Inc. (PALI)
NASDAQ: PALI
· Real-Time Price · USD
0.81
-0.00 (-0.61%)
At close: Aug 15, 2025, 12:39 PM
Palisade Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 4K | n/a | n/a | n/a | -250K | n/a | n/a | 250K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1K | 1K | 2K | 1K | 1K | 1K | 54K | 1K | 27K | 26K | 26K | 46K | 49K | 46K | 44K | 42K | n/a | 9.03K |
Gross Profit | -1K | -1K | 2K | -1K | -1K | -1K | -304K | -1K | -27K | 224K | -26K | n/a | -49K | -46K | -44K | -42K | n/a | -9.03K |
Operating Income | -2.84M | -2.31M | -3.38M | -3.59M | -4.21M | -3.67M | -3.15M | -3.78M | -3.61M | -2.53M | -3.85M | -4.41M | -3.57M | -3.89M | -4.03M | -3.02M | -32.86M | -1.95M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.92K |
Pretax Income | -2.78M | -2.23M | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M | -3.6M | -3.39M | -2.34M | -3.72M | -3.99M | -2.34M | -4.21M | 1.07M | 8.09M | -31.75M | -2.29M |
Net Income | -2.78M | -2.23M | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M | -3.6M | -3.39M | -2.34M | -3.72M | -3.99M | -2.34M | -4.21M | 1.07M | 8.09M | -31.75M | -4.03M |
Selling & General & Admin | 1.17M | 1.36M | 1.3M | 1.46M | 1.58M | 1.46M | 1.56M | 1.67M | 1.43M | 1.54M | 1.5M | 2.08M | 2.25M | 2.93M | 3.23M | 2.39M | 2.43M | 1.26M |
Research & Development | 1.68M | 950K | 2.08M | 2.14M | 2.63M | 2.21M | 1.73M | 1.74M | 2.18M | 1.24M | 2.34M | 1.93M | 1.32M | 959K | 800K | 624K | 314K | 692K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 187K | 362K | n/a | n/a | n/a | 410K | 8K | 1K | 11K | 38K | 30.12M | n/a |
Operating Expenses | 2.84M | 2.31M | 3.38M | 3.59M | 4.21M | 3.67M | 3.29M | 3.78M | 3.61M | 2.78M | 3.85M | 4.41M | 3.57M | 3.89M | 4.03M | 3.02M | 32.86M | 1.95M |
Interest Expense | 2K | 1K | 3K | 6K | 2K | 1K | 4K | 8K | 3K | 189K | 3K | 4K | 5K | 1K | 5K | 26K | 655K | 1.71M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.84M | 2.31M | 3.38M | 3.59M | 4.21M | 3.67M | 3.29M | 3.78M | 3.61M | 2.78M | 3.85M | 4.41M | 3.57M | 3.89M | 4.03M | 3.02M | 32.86M | 1.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26K | n/a | 1.71M |
Shares Outstanding (Basic) | 4.8M | 4.8M | 5.82M | 5.82M | 5.82M | 768.14K | 5.82M | 489.62K | 6.4M | 4.32M | 1.8M | 64.95K | 405.9K | 324.45K | 270.66K | 16.13K | 152.43K | 832.35K |
Shares Outstanding (Diluted) | 4.8M | 4.8M | 8.54M | 5.82M | 5.82M | 12.63M | 9.27M | 489.62K | 427.86K | 287.7K | 1.8M | 64.95K | 405.9K | 324.48K | 270.66K | 242.13K | 176.63K | 237.39K |
EPS (Basic) | -0.58 | -0.46 | -0.57 | -2.32 | -3.32 | -4.59 | -0.51 | -7.38 | -7.93 | -8.13 | -1.49 | -61.5 | -86.55 | -194.4 | 3.96 | 315.00 | -208.27 | -4.84 |
EPS (Diluted) | -0.58 | -0.46 | -0.39 | -2.32 | -3.32 | -4.59 | -0.32 | -7.38 | -7.93 | -8.13 | -1.49 | -61.5 | -2.75 | -13.94 | 3.96 | 33.40 | -179.74 | -16.98 |
EBITDA | -2.78M | -2.23M | -3.34M | -3.48M | -4.08M | -3.52M | -2.97M | -3.59M | -3.39M | -2.31M | -3.71M | -3.99M | -2.29M | -4.16M | 1.12M | 8.11M | -31.09M | -2.32M |
EBIT | -2.78M | -2.23M | -3.34M | -3.48M | -4.08M | -3.53M | -2.97M | -3.59M | -3.39M | -2.34M | -3.72M | -3.99M | -2.34M | -4.2M | 1.08M | 8.11M | -31.09M | -2.28M |
Depreciation & Amortization | 1K | 1K | -3K | 1K | 1K | 1K | 43.81K | 1K | 27K | 26K | 26K | 46K | 49K | 46K | 44K | 42K | 1K | 1K |